Drug
Fdc Tiotropium Salmeterol
Fdc Tiotropium Salmeterol: highest development phase Phase 3, developed by Boehringer Ingelheim. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Boehringer Ingelheim
Trials
| Drug | Phase | Indication |
|---|---|---|
| FDC tiotropium / salmeterol NCT00662740 | Phase 3 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Fdc Tiotropium Salmeterol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.